rilmenidine has been researched along with Arrhythmias, Cardiac in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 5 (71.43) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T; Yamanaka, H; Yamatodani, A | 1 |
| Hayashi, Y; Iwasaki, M; Kamibayashi, T; Mashimo, T; Yamatodani, A | 1 |
| Hayashi, Y; Kamibayashi, T; Mammoto, T; Takada, K; Yamatodani, A; Yoshiya, I | 2 |
| Bousquet, P; De Jong, W; Feldman, J; Monassier, L; Roegel, JC; Yannoulis, N | 1 |
| Lada, W | 1 |
| Bousquet, P; Feldman, J | 1 |
2 review(s) available for rilmenidine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
[Imidazoline receptors and use of drug blocking receptors I1].
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Antihypertensive Agents; Arrhythmias, Cardiac; Cimetidine; Histamine H2 Antagonists; Humans; Hypertension; Imidazoles; Myocardial Infarction; Oxazoles; Rilmenidine | 1996 |
Drugs acting on imidazoline receptors: a review of their pharmacology, their use in blood pressure control and their potential interest in cardioprotection.
Topics: Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Clinical Trials as Topic; Heart Failure; Humans; Hypertension; Imidazoles; Imidazoline Receptors; Oxazoles; Receptors, Drug; Rilmenidine | 1999 |
5 other study(ies) available for rilmenidine and Arrhythmias, Cardiac
| Article | Year |
|---|---|
Activation of phosphatidylinositol 3-kinase/Akt signaling pathway and endogenous nitric oxide are needed for the antiarrhythmic effect of centrally administered rilmenidine.
Topics: Androstadienes; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; Halothane; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxazoles; Phosphatidylinositol 3-Kinase; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Proto-Oncogene Proteins c-akt; Rats; Rats, Sprague-Dawley; Receptors, Cell Surface; Rilmenidine; Signal Transduction; Sympathomimetics; Wortmannin | 2010 |
The antiarrhythmic effect of centrally administered rilmenidine involves muscarinic receptors, protein kinase C and mitochondrial signalling pathways.
Topics: Adrenergic alpha-Agonists; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Epinephrine; KATP Channels; Male; Mitochondrial Membrane Transport Proteins; Mitochondrial Permeability Transition Pore; Oxazoles; Protein Kinase C; Rats; Rats, Sprague-Dawley; Receptors, Muscarinic; Rilmenidine | 2008 |
Rilmenidine prevents epinephrine-induced arrhythmias in halothane-anesthetized dogs.
Topics: Adrenergic alpha-Agonists; Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Dogs; Dose-Response Relationship, Drug; Epinephrine; Female; Halothane; Imidazoline Receptors; Male; Oxazoles; Receptors, Drug; Rilmenidine | 1995 |
Antiarrhythmic action of rilmenidine on adrenaline-induced arrhythmia via central imidazoline receptors in halothane-anaesthetized dogs.
Topics: Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Analysis of Variance; Anesthetics, Inhalation; Animals; Arrhythmias, Cardiac; Blood Pressure; Dogs; Epinephrine; Female; Halothane; Heart Rate; Idazoxan; Imidazoline Receptors; Male; Oxazoles; Receptors, Drug; Rilmenidine; Yohimbine | 1996 |
Inhibition of centrally induced ventricular arrhythmias by rilmenidine and idazoxan in rabbits.
Topics: Adrenergic alpha-Antagonists; Analysis of Variance; Animals; Antihypertensive Agents; Arrhythmias, Cardiac; Bicuculline; Blood Pressure; Dose-Response Relationship, Drug; GABA Antagonists; Heart Rate; Idazoxan; Injections, Intravenous; Male; Oxazoles; Rabbits; Rilmenidine | 1996 |